Loading...
Market
Increase in Synthetic DNA Costs Due to New Screening by 2024
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Price listings on company websites or industry reports
Story
U.S. White House Policy Tightens Regulation on Synthetic DNA
May 8, 2024, 08:43 AM
The U.S. government is intensifying its efforts to regulate synthetic DNA, a move supported by industry leaders and biosecurity experts. A new White House policy aims to standardize the screening processes across companies like Twist Bioscience that produce and distribute synthetic DNA. This initiative seeks to prevent misuse by ensuring that providers verify both the sequences ordered and the credentials of those ordering them. Emily Leproust of Twist Bioscience welcomed the policy, emphasizing the ethical responsibility in promoting responsible research and rigorous screening of synthetic DNA.
View original story
Similar markets
High adoption by healthcare sector • 25%
High adoption by agricultural sector • 25%
Low adoption by healthcare sector • 25%
Low adoption by agricultural sector • 25%
EU introduces similar policies • 25%
China introduces similar policies • 25%
India introduces similar policies • 25%
No major regions introduce similar policies • 25%
Highly effective • 33%
Moderately effective • 33%
Not effective • 33%
Increase • 33%
Decrease • 33%
Remain the same • 34%
Pharmaceuticals • 25%
Biotechnology research • 25%
Medical devices • 25%
Genomics • 25%
